We have issued an updated research report on IDEX Corporation (IEX - Free Report) on Dec 26.
This industrial machinery currently carries a Zacks Rank #4 (Sell). Its market capitalization is approximately $9.1 billion.
Let’s delve deeper and discuss what led to the company’s poor investment appeal.
Share Price Performances, Poor Valuation & Earnings Estimate Revision: Market sentiments are currently against IDEX. Its stock price has decreased roughly 22.1% in the past three months versus the industry’s decline of 21.8%.
The company’s stock appears overvalued compared with the industry. On a Price/Earnings (P/E) basis, the stock is currently trading at 22.7x, higher compared with the industry’s 14.3x. Further, the stock’s current valuation multiple is above the industry’s highest levels for the past three months of 18.6x.
In the past 60 days, earnings estimates on the stock have remained unchanged at $5.36 per share for 2018. However, accounting for one downward revision, earnings estimates for 2019 have declined 0.2% from the 60-day-ago tally to $5.76.
IDEX Corporation Price and Consensus
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
We have issued an updated research report on IDEX Corporation (IEX - Free Report) on Dec 26.
This industrial machinery currently carries a Zacks Rank #4 (Sell). Its market capitalization is approximately $9.1 billion.
Let’s delve deeper and discuss what led to the company’s poor investment appeal.
Share Price Performances, Poor Valuation & Earnings Estimate Revision: Market sentiments are currently against IDEX. Its stock price has decreased roughly 22.1% in the past three months versus the industry’s decline of 21.8%.
The company’s stock appears overvalued compared with the industry. On a Price/Earnings (P/E) basis, the stock is currently trading at 22.7x, higher compared with the industry’s 14.3x. Further, the stock’s current valuation multiple is above the industry’s highest levels for the past three months of 18.6x.
In the past 60 days, earnings estimates on the stock have remained unchanged at $5.36 per share for 2018. However, accounting for one downward revision, earnings estimates for 2019 have declined 0.2% from the 60-day-ago tally to $5.76.
IDEX Corporation Price and Consensus
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on IEX - FREE
Get the latest research report on DXPE - FREE
Get the latest research report on NPO - FREE
Get the latest research report on LXFR - FREE